Nuveen S&P 500 Dynamic Overwrite Fund (SPXX)

R&D to Revenue

0.00%

Quarterly · Period ending:

SPXX logo

SPXX R&D to Revenue

Latest reported0.00%
SPXX Quarterly R&D/Revenue (0.00% → 0.00%)
High-resolution chart · PNG

SPXX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuveen S&P 500 Dynamic Overwrite Fund R&D to Revenue — Quarterly
Period endingR&D to Revenue
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.